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Abstract.  
Plants of the Amaryllidaceae family are well-known (not only) for their ornamental 
value but also for the alkaloids they produce. In this report, the first phytochemical study of 
Clinanthus genus was carried out. The chemical composition of alkaloid fractions from 
Clinanthus microstephus was analyzed by GC-MS and NMR. Seven known compounds 
belonging to three structural types of Amaryllidaceae alkaloids were identified. An 
epimeric mixture of a haemanthamine-type compound (6-hydroxymaritidine) was tested as 
an inhibitor against acetyl and butyryl cholinesterase enzymes (AChE and BChE, 
respectively), two enzymes relevant in the treatment of Alzheimer’s Disease, with good 
results. Structure-activity relationships through molecular docking studies with this alkaloid 
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Introduction 
Amaryllidaceae species are known as ornamental plants that produce alkaloids with 
a wide range of interesting biological activities, such as antimalarial, antitumoral, antiviral, 
cholinesterase inhibition, among others.[1-3] Many Amaryllidaceae species have been 
extensively used in traditional medicine to treat a variety of health problems and as a 
promising source for new and bioactive molecules.[4] Within all the bioactive alkaloids 
reported in this family,[5, 6] the compound galanthamine worth to be mentioned. It was 
approved as a prescription drug by the FDA for the treatment of Alzheimer´s disease (AD) 
due to its high inhibitory efficacy, through a competitive, reversible and selective 
mechanism on acetylcholinesterase enzyme (AChE).[7, 8]  
AD is the most predominant cause of dementia in the elderly population. Recent 
studies indicate a clear increase in its prevalence. Today, 47 million people live with 
dementia worldwide. This number is projected to increase to more than 131 million by 
2050, at a similar rate as the increase in life expectancy.[9] Therefore, AD is a major public 
health concern and has engaged significant research efforts.  
AD patients present a deficit of the cholinergic functions, such as memory 
impairments and loss of intellectual abilities, due to decreased levels of the critical cationic 
neurotransmitter acetylcholine (ACh) in the cortex.[10] This neurotransmitter is quickly 
hydrolyzed by AChE, finishing with the nerve impulse transmission at cholinergic 
synapsis. For this reason, a palliative strategy employed to treat symptoms of the disease is 
to inhibit the action of AChE, increasing the level of ACh in presynaptic space.[11, 12] Also, 
the inhibition of this enzyme is related to other types of neurodegenerative diseases such as 
senile dementia, ataxia, myasthenia gravis, and Parkinson´s disease.[13] The enzyme 
butyrylcholinesterase (BChE) is also involved in the metabolic degradation of ACh. In AD 
patients, the AChE/BChE ratio depends on the brain region and the stage of the disease 
progression. BChE can compensate AChE activity when its levels are decreased. Since 
BChE activity increases as AD progresses, this enzyme may also play an important role in 
cholinergic dysfunction, particularly in the later stages of AD.[14] 
In recent years, alkaloids from the Amaryllidaceae family have received great 
attention due to their well-known anticholinergic activity, which generally have in common 
the presence of nitrogen atoms in a heterocyclic ring. The chemical structures of these 
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has motivated the search of more potent and effective AChE inhibitors (AChEIs) from 
Amaryllidaceae species leading to the isolation of different active alkaloids. [15, 16]  
From this perspective, one of the plant families of our interest is the Amaryllidaceae 
family. This botanical family is richly represented in the tropics and has significant centers 
of diversity in the Andean region of South America.[17] In Peru, the varied climatic and 
geographical conditions have allowed a great diversity of flora to explore, with a great 
number of species to be discovered. This region is a major center of diversity for the genus 
Clinanthus which contains between 15 and 20 non-monographed species.[18] Therefore, the 
need for preliminary studies is imperative in order to know their phytochemical 
composition. 
Given the increased inhibitory activity shown by the alkaloids of this family on the 
AChE enzyme and considering that the genus Clinanthus does not possess any previous 
phytochemical studies to date, in this manuscript we report the first phytochemical study of 
the Peruvian bulbous plant Clinanthus microstephus (Ravenna) Meerow in the search of 
bioactive alkaloids and with the aim to contribute to the taxonomy of the Clinanthus 
genus.[19] The purpose of the study was to begin the revision of recently described species 
of the Peruvian flora.  
In addition, to understand the differences in the AChE inhibitory activity displayed 
by different alkaloids from Amaryllidaceae family, molecular modeling studies were 
performed. 
Results and Discussion 
One fresh bulb of C. microstephus was extracted exhaustively with methanol (1 L). 
After concentration and subsequent acid-base extractions of the crude extract, an alkaloidal 
fraction (approximately 100 mg) was obtained. This residue was fractionated by a 
combination of chromatographic techniques, ultimately giving nineteen fractions of very 
low mass (see experimental section for details). According to the 1H-NMR analysis, most 
of them were a complex mixture of alkaloids and in many cases, they could not be purified 
given the low quantities available. Only three of them could be analyzed by CG-MS 
(renamed A, B, and C). Despite the complexity of these fractions, some reported alkaloids 
were identified (they are summarized in Table 1). Their identification was performed by 
comparison of retention times and mass spectra, with the information from reference 
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elucidation of 6-hydroxymaritidine (hereafter named as compound 1 isolated in fraction C 
almost as main component), recently isolated from Hippeastrum reticulatum 
(Amaryllidaceae).[20] This compound (figure 1) was isolated as a  epimeric mixture, 
83:17.[21] All the spectral data (NMR assignments, HRESIMS and mass fragmentation 
pattern observed in the GC-MS) are in agreement with the information reported in the work 

























Figure 1. epimeric mixture of 6-hydroxymaritidine 
The remaining fractions (A and B) were analyzed by GC-MS to identify the 
alkaloids in the obtained mixtures, due to their low quantity and complexity. GC-MS 
analysis has demonstrated to be a useful, robust and efficient technique for the rapid 
identification and/or quantification of many complex mixtures of alkaloids from 
Amaryllidaceae plant extracts.[22, 23]  
Seven alkaloids of three structural types were identified by GC-MS analysis (Table 
1). The area of the GC-MS peaks depends not only on the corresponding compounds, but 
also on the intensity of their MS fragmentation (response factor). Thus, data given in the 
table represent relative ratios that can be used for comparison between samples, though 
they do not correspond strictly to a quantification. 
Table 1. Alkaloids identified by GC-MS analysis of fractions A, B and C 
Fraction Compound tR (min) 
[M]+ [m/z (% 
relative 
intensity)] 
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Lycorine (VI) 
     25.2 287 (40) 
288 (15), 286 
(15), 268 (20), 






     22.1 303 (15) 
285 (15), 260 
(25), 259 (100), 
256 (25), 241 
(70), 115 (30), 
77 (20) 
43.6 
1D and 2D 
NMR spectra 
a Values are expressed as a percentage of the total ion current (TIC) of every fraction. 
Biological activity, molecular docking and structure–activity relationship 
One of the main objectives of our research group is the exploration of the chemical 
diversity of natural compounds in search of bioactive metabolites. Due to the marked 
biological activity as cholinesterase inhibitors that this family of compounds presents and 
since the epimeric mixture of 6-hydroxymaritidine was obtained in appropriate quantity and 
purity, it was re-evaluated for their AChE and BChE inhibitory activities (using 
galanthamine as reference compound). In addition, a docking study was performed 
including a group of alkaloids structurally related and previously reported. The main 
purpose was to deepen the analysis of interactions with the enzyme through a detailed 
structure-activity analysis. 
Acetyl- and Butyrylcholinesterase inhibitory activities 
Compound 1 as an epimeric mixture, was tested for in vitro inhibition of 
cholinesterase on the commercially available eel AChE and horse serum BChE (results are 
summarized in Table 2). The activity was determined according to the method of Ellman et 
al. with slight modifications.[24] The inhibition percentages obtained after 3 replications at 
25 µM, were shown to be interesting (70.1% for AChE and 87.9% for BChE) and IC50 was 
calculated in both assays. For comparison purposes, galanthamine was used as a reference 
inhibitor. 
It is noteworthy that this IC50 value for compound 1 is quite different from those 
recently reported for this alkaloid.[20] This different outcome may be attributed to the 
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although the conditions are similar, the results for the same compound (for example 
galanthamine) present variations (in Supporting Information, Table S1 summarizes some 
differences found). In this study, MeOH (2.5 %) was used as a cosolvent to improve and 
guarantee alkaloid solubility in the buffer where the assay was carried out. Also, the 
incubation of the enzyme along with the inhibitors for longer periods of time before adding 
the reactive according to the optimized Ellman protocol in our research group (See 
experimental section and Supporting Information for a more detail explanation). 
Furthermore, it is interesting to note that it is essential to carry out the measurement of 
positive control in each assay or study in particular.  
 
Table 2. AChE and BChE inhibitory activity of the tested alkaloids expressed as IC50 
values. 
 
Compound IC50 AChE (M) IC50 BChE (M) 
1 
 
10.53 ± 1.19 
 
       9.51 ± 1.24 
Galanthamine 
 
0.76 ± 0.01 
 
23.85 ± 1.12 
All results are expressed as IC50 values (M). Each value is the mean of three replications. 
IC50 values for AChE inhibition for compound 1 and related alkaloids (previously 
reported in bibliography) are summarized in Table 3 for comparison purposes and to obtain 
structure-activity relationships. As it can be observed, beyond galanthamine, epimeric 
mixture 1 showed the best IC50 value (10.35 ± 1.19 μM) among the other related structures 
for AChE inhibition.   
Molecular modeling studies were performed to investigate key interactions of these 
compounds with the enzymes and the role that the structural differences between them may 
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In addition, the contribution and the differential composition of the isomers according to 
the physiological pH was also evaluated.   
Structure-activity analysis through Molecular Docking  
To date, there is information from hundreds of isolated alkaloids in the 
Amaryllidaceae plant family. Some of them with very promising activities as AChEIs. 
Performing structure-activity relationship studies from molecular modeling results is 
sometimes difficult. This is due to the high variability of compounds and the quantity and 
structural diversity of isolated nuclei in the same species.[31] In the area of medicinal 
chemistry, the "similarity paradox"[32] establishes that small structural changes in molecules 
can drastically impact their biological activity. So, it is important to carry out an analysis of 
the molecular interactions between inhibitor and protein that determine the activity 
found.[33, 34] 
Numerous reports consider that alkaloids are the most promising candidates within 
the products of natural origin for use in AD.[35] This is because of their complex structures 
that contain at least one nitrogen atom.[36] Structure-activity studies have demonstrated that 
the ability of the nitrogenous functionalities to be positively-charged at physiological pH is 
one of the most important characteristics related to the potency of these compounds. This 
ensures the interaction with key sites of the AChE enzyme cavity.[37]  
AChE inhibitors are interesting since they could restore the cholinergic deficit by 
blocking the catalytic site of the enzyme. Several studies showed that one of the remarkable 
features of the structure of the AChE enzyme[38] is the presence of a "catalytic cavity" of 
approximately 20 Å depth and 4.5 Å narrow channel. This one possesses an active site 
where the neurotransmitter is hydrolyzed. The residues responsible for the catalytic activity 
(Ser, His and Glu), are known as “catalytic triad". In the active site there are also three 
additional subsites; anionic, oxyanionic and acyl binding. At the surface of the cavity, there 
is a region called peripheral anionic site (PAS, allosteric site) that is related to the inhibition 
of other neurodegenerative processes.[39] Between the active site and PAS there is a region 
called "bottleneck" formed by Phe and Tyr that regulates the entrance of different 
substrates (see Figure S3 in Supporting Information for visualization).  
As mentioned above, AChE plays an important biological function and knowing the 
possible interactions of the substrates in the three-dimensional structure of the enzyme is 
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structural types: two epimers, as their neutral and protonated forms) together with some 
structurally related structural compounds and galanthamine were subjected to molecular 
docking studies.  
To carry out the simulations, the geometry of the receptor was taken from the X-ray 
structure of the complex between AChE from Torpedo Californica (TcAChE) and 
Galanthamine (PDB: 1W6R). In addition, for comparative purposes, docking calculations 
over BChE from human (hBChE) were performed (PDB: 1P0I). The geometries of the 
complexes with the inhibitors were obtained using AutoDock4.2.6 program (Gasteiger 
charges were applied). After docking calculations, a minimization of each complex was 
made with Sander program and the binding energy re-scored within the MM-GBSA 
method (Amber16 package).  
The calculated pKa value for compound 1 is 7.24 so at physiological pH, both the 
neutral and protonated species could be found. Furthermore, in solution the compound 1 is 
presented as an epimeric mixture on C-6. Therefore, there are four species that may be 
participating in the interaction with the enzyme. As the protonation state can affect the 
interaction, it must be considered. For this reason, all these species were included in the 
docking calculations. 
The lowest binding energies obtained with MM-GBSA method were used for the 
analysis. The results suggest that the protonated form of the β-epimer (β +), with more 
negative binding energy, is the species that presents a more stable binding mode with the 
protein. Interestingly, this is the major epimer of the isolated mixture (as shown by the 
NMR essays). To estimate the conformers ratio in water (the media in which the IC50 were 
determined) quantum calculations were carried out with the protonated species. The 
estimated ratio obtained by DFT calculations is ~4:1 in accordance with the experimental 
value found in chloroform. In order to know more about the relative stability of the 
epimeric species, the energy difference between the two epimers with two DFT functionals 
was calculated (B3LYP and M06-2X). It was observed that in both cases the -epimer is 
the most stable. In one case an energy difference of 0.73 kcal/mol was obtained with a 
0.77:0.23 molar ratio; in the second case, the energy difference is 0.94 kcal/mol with a 
0.83:0.17 molar ratio. This is another important point to consider since the composition of 
the isolated epimeric mixture is slightly different from those recently reported for this 
alkaloid (slightly larger for the -epimer).[20] As it was obtained from the modeling studies, 
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For these reasons, the analysis of docking results and interactions with the protein 
was carried out with the  + species, Figure 2 A. The results suggest three fundamental 
interactions; basically, van der Waals type interactions between skeleton rings A, B, and 
Trp84 belonging to the anionic subsite. Also, this type of interaction was observed between 
rings B-C, and residues Gly117 and Gly118. Besides, a hydrogen bond between the 
hydroxyl of C-3 with Ser200 of the catalytic triad.  In this case, hydroxyl group participates 
as hydrogen bond donor to the oxygen of the side chain of the Ser200. The most important 
interaction is established with Glu199 of the anionic subsite (binding decomposition energy 
of -21.51 kcal/mol). This interaction can be split into two main contributions: firstly, the 
carboxylate of Glu199 establishes a salt bridge interaction with (R3N-H)+ group and 
secondly interacts with the hydroxyl group of C-6. 
The analysis of the obtained complexes with BChE reveals that the -epimer, in its 
protonated form, presents the most stable binding mode (binding energy: -59.27 kcal/mol), 
see Figure S5 in Supporting Information for details. The docking showed that this 
compound binds to the bottom of the active site of the enzyme. From the energy 
decomposition, it is possible to see that the most important interaction is with Glu197. The 
relevance of this interaction is a consequence of the sum of two important interactions. One 
of them is a hydrogen bond between carboxylate of this residue and the hydroxyl group of 
C-6; and the second one, is a salt bridge with (R3N-H)+ group. In addition, van der Waals 
interaction is observed between Trp82 belonging to the anionic subsite and two hydrogen 
bond with Gly116 (oxyanionic subsite) and His438 (catalytic triad).[33]  
On the other hand, galanthamine binds at the base of the active site gorge in both 
enzymes. Particularly, the calculated geometry for AChE was close to the experimental 
with a low RMSD, thus validating the protocol used. In Figure S4 (supplementary material) 
AChE-galanthamine complex geometry is shown as an example. It is possible to 
distinguish hydrogen bond type interactions with Glu199 and the C-3 hydroxyl group (1.58 
Å). The rest of interactions are van der Waals type. Particularly, rings A and D of the 
inhibitor interact with Trp84, the rings A-B-C with Gly117 and Gly118, and C and D with 
Tyr121 and Phe330. The main differences in the poses adopted by both inhibitors 
(galanthamine and compound 1, most stable epimer and protonated state) in the enzyme 
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If compound 1 and galanthamine are compared, a certain structural similarity can be 
observed. Variable rigidity-flexibility characteristics in rings A-B-C-D are observed, this 
fact based on the different biogenetic approximations of both compounds. These distinctive 
arrangements result from para-para´ (haemanthamine skeleton type) or para-ortho´ 
(galanthamine skeleton type) phenol oxidative coupling.[40] Regarding alkaloidal skeleton 
type, in this compound there is a differential rigidity of rings. This means that the A ring 
has an arrangement almost perpendicular to the plane formed by the other rings. This 
feature generates differential interactions from those observed for compound 1 in a totally 
different geometry. The most notable difference relies on the more favorable interaction 
with Glu199 for compound 1 respect to galanthamine (from -21.51 kcal to -6.62 kcal, 
respectively). Probably since there is no direct relationship between the binding energy and 
the inhibitory activity found for both compounds, as claimed by other authors,  the high 
affinity displayed by galanthamine for AChE appears to come from several moderate to 
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Figure 2. Calculated position of compound 1 (A) and galanthamine (B) in the 
binding pocket of the TcAChE and most relevant residue interactions. Per-residue 
contributions to the binding energy calculated with MM-GBSA method. The most stable 
epimer of 1 in its protonated state formed the most stable complex, that is represented in 
this figure. 
Analysis of docking results for compound 1 and structurally related alkaloids, 
allows establishing some structure-activity relationships, as discussed below (see Figures 
S6 to S11 in Supporting Information where calculated complexes in the binding pocket of 
TcAChE and most relevant inhibitor-protein interactions for compounds 2-7 are presented).   
Compound 2 [43, 44] differentiates itself from 1, by an O-methyl group on C-3 instead 
of the hydroxyl. This structural change is responsible for the loss of the stabilizing 
hydrogen bond interaction with Ser200. It establishes a van der Waals type interaction, but 
the stabilizing effect is smaller. In addition, the interaction with Gly117 (van der Waals 
type) is weaker. The depletion in the interactions, in comparison to 1, causes that this 
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With respect to 2, compound 3 [43, 44] has the reduced the C-6 position, losing the 
hydrogen bond interaction with Glu199 of the anionic site, but still retaining the salt bridge 
interaction between the group (R3N-H)+ and the carboxylate of this residue. In the binding 
energy decomposition graphic, could be seen that this interaction decreased from -21,5 
(compound 1) to -17.4 kcal/mol. 
Although the inhibitor 4[45] does not possess the hydrogen bond interactions with 
Ser200 and Glu199, demethylation of hydroxyl group in the aromatic ring, allowed the 
formation of a new hydrogen bond interaction with Ser122 belonging to the peripheral 
anionic site. In this case, hydrogen of the aromatic hydroxyl group is the donor to oxygen 
of hydroxyl group of Ser122 side chain. Although in terms of inhibitory activity this change 
is not appreciable, possibly, this new interaction could be responsible for making this 
compound active compared with the compounds 2 and 3.  
In compound 5,[43, 44] as it was in compound 3, hydroxyl group of C-6 is absent. 
According to this, primary interaction with Glu199 is substantially reduced (from -21.5 to -
16.9 kcal/mol) as well as van der Waals type interaction with Gly117. The attenuation of 
the interactions could be the reason whereby this compound does not possess inhibitory 
activity. 
Compared to structure 5, compound 6 [46, 47] has a demethylation of one of O-CH3 
aromatic group (C-8) making possible a hydrogen bond interaction with the carbonyl group 
of Trp84 residue. For this reason, interactions with this residue were reinforced going from 
-9.2 to -11.7 kcal/mol. This new interaction, product of a simple modification of compound 
5, could be the cause why compound 6 becomes an inhibitor of moderate activity. 
On the other hand, if the simple chemical modification of the addition of the 
aromatic OH is taken as a basis to enable hydrogen bridge interaction with Ser 122 (as 
observed when introducing this modification of compound 3 to 4), no substantial inhibitory 
activity improvement is obtained for compound 7 [45] compared with 5. 
In general terms, considering the interactions with AChE described for the analyzed 
compounds, the haemanthamine skeleton could not reach the efficient levels of inhibition 
presented by galanthamine. However, the IC50 value showed by compound 1 is just one 
order less active than that of galanthamine, being the best among the other structurally 
related alkaloids analyzed. Regarding the importance of the substituents of the 
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necessary to establish a good interaction with the enzyme, being C-3 and C-6 the most 
favorable positions. 
Table 3. Summary of in vitro AChE inhibition activity of compound 1 and reported related 
compounds.a Binding energy calculated by rescoring of the geometries obtained with 
molecular docking. 
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57.4 [46, 47] -56.1 
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a Results are expressed as IC50 values (M). Each value is the mean of three replications. 
 
Conclusions 
To our knowledge, this is the first phytochemical study of a species from the 
Clinanthus genus, representing a starting point in the exploration of new chemotaxonomic 
markers at a generic level in this family. Indeed, in this study it is shown that the genus 
Clinanthus as well as others of the Amaryllidaceae family possess at least alkaloids of 
lycorine, homolycorine, and haemanthamine types. This reaffirms the fact that these 
metabolites are chemotaxonomic markers of this family. In this respect, the exploration of 
native Peruvian flora is an interesting topic to be addressed because of the variability of 
alkaloidal structures. 
For the classification of plant species, traditional systematic focus mainly on 
morphological and anatomical characteristics; usually chemical content and 
chemotaxonomy play a minor role in the classification. However, secondary metabolites 
can provide valuable information for the characterization of taxa at different levels. Several 
authors have carried out interdisciplinary approaches combining the chemical and botanical 
aspects, and in fact, the chemosystematics has been used in order to solve various 
taxonomic problems or to support the botanical findings. Due to the previously exposed 
reasons, the contribution to the systematic classification of plant species through their 
phytochemical study represents a subject of relevance for natural sciences. 
AChE still represents an attractive target for rational drug design and discovery of 
mechanism-based inhibitors for the treatment of Alzheimer´s disease. Our results 
summarize reports of other groups, tending to improve the structure-activity relationships 
for the finding of increasingly active derivatives and suggest that these alkaloids could be 
potential candidates for further development of new drugs against AD. Indeed, evidence 
suggest that a minimal structural variation (different isomers for example), could impact in 
biological activity in this compound´s family. The results obtained from docking studies are 
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with the enzymes TcAChE and hBuChE. Structure-activity analysis help to explain the 
differences in the inhibitory activity of alkaloids with galanthamine skeleton type 
(galanthamine) and alkaloids with haemanthamine skeleton, compounds 1 to 7.  
For all these reasons, C. microsthepus is an interesting species to be exhaustively 
addressed from other perspectives of importance due to the presence of active metabolites. 
 
Materials and methods 
General 
Optical rotation was measured on JASCO P-1010 polarimeter. IR spectra were 
obtained in a Nicolet 5-SXC spectrophotometer (each compound was dissolved in a 
minimum amount of solvent and a drop of solution was added to the AgCl IR plates). NMR 
experiments were performed on Bruker AVANCE II 400 MHz instrument. Multiplicity 
determinations (HSQC-DEPT) and 2D spectra (COSY, HSQC and HMBC) were obtained 
using standard Bruker software. Chemical shifts are expressed in ppm () units using 
tetramethylsilane as the standard. HR-ESI-QTOF-MS were measured on a Micro QTOF II 
Bruker Daltonics (MA, USA) mass spectrometer. Chromatographic separations were 
performed by column chromatography on silica gel 60 (0.063–0.200 mm), and preparative 
TLC on silica gel 60 F254 (0.2 mm thick) plates. Presence of alkaloids was revealed by 
Dragendorff’s reagent. Acetylcholinesterase from electric eel (type VI-S), 5,50-dithiobis 
(2-nitrobenzoic acid) (DTNB), acetylthiocholine iodide (ATCI), butyrylthiocholine iodide 
(BTCI) and galanthamine (99%) were purchased from Sigma. BChE (horse serum) was 
purchased from MP Biomedicals.  
Plant material 
C. microstephus was collected in Departamento La Libertad, Otuzco, Salpo region 
and El Tablón-Rayampampa, Perú (8o00’39,9”S y 78o40’04,1” W, 1927 m) in January 
2015 (code: S. Leiva & M. Leiva 5703 (HAO, HUT); North of Rayampampa, 8o00’47,0”S y 
78o40’06,2” W, 1981 m, February 2015 S. Leiva & M. Leiva 5716 (CORD, HAO).[19] A 
voucher specimen of C. microstephus was identified by Professor Segundo Leiva and was 
deposited at the herbarium of Museo de Historia Natural y Cultural, Universidad Privada 
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Extraction and Isolation 
One fresh bulb (109.5 g) was grounded and extracted with MeOH (1 L). The solvent 
was then evaporated under reduced pressure using a rotary evaporator. The total dried 
residue was diluted with aqueous HCl solution (200 mL, 10%). Diatomaceous earth was 
added, and the homogenate was placed at 2°C for 12h. Afterward, the aqueous phase was 
vacuum filtrated. The resulting fraction was partitioned in CH2Cl2 (3 x 100 mL). The pH of 
the aqueous acidic fraction was adjusted to 9 with NH4OH and extracted with CH2Cl2 (5 x 
100 mL). Organic extract was dried over anhydrous Na2SO4, filtered, and evaporated to 
dryness at reduced pressure. The residue was fractionated initially by silica gel 60 G 
chromatography. Elution with CH2Cl2: MeOH (10:0 to 8:2) afforded 7 fractions.  
All these fractions were purified by preparative TLC (CH2Cl2: MeOH, sequentially 
10:0 to 8:2). From the nineteen resulting fractions, only three of them could be analyzed by 
CG-MS (renamed A, B, and C). Despite the low amount of sample and the level of 
complexity, 1 and 2D NMR spectra could be obtained from some of the purified 
compounds (1, III and V). Compound 1 was obtained as an epimeric mixture [4.2 mg, 
83():17(), approximately obtained ratio by 1H-NMR signal integration], from fraction C, 
and completely characterized by 1 and 2D NMR.[20] Analytical and spectral data obtained 
for this alkaloid agree with those reported in the literature for structurally related 
compounds.[48]  
 
Cholinesterase inhibition assay 
Electric eel AChE and horse serum BChE were used as a source of both the 
cholinesterases. AChE and BChE inhibiting activities were measured in vitro by the 
spectrophotometric method developed by Ellman with slight modification.[24] The 
lyophilized enzyme, 500U AChE /300U BChE was prepared in buffer A (8 mM K2HPO4, 
2.3 mM NaH2PO4) to obtain 5/3 U/mL stock solution. Further enzyme dilution was carried 
out with buffer B (8mM K2HPO4, 2.3 mM NaH2PO4, 0.15 M NaCl, 0.05% Tween 20, pH 
7.6) to produce 0.126/0.06 U/mL enzyme solution. Samples were dissolved in buffer B 
with 2.5% of MeOH as cosolvent. Enzyme solution (300 μL) and sample solution (300 μL) 
were mixed in a test tube and incubated for 60/120 min at room temperature. The reaction 
was started by adding 600 μL of the substrate solution (0.5 mM DTNB, 0.6 mM 














This article is protected by copyright. All rights reserved.
27ºC. Enzyme activity was calculated by comparing reaction rates for the sample to the 
blank. All the reactions were performed in triplicate. IC50 values were determined with 
GraphPad Prism 5. Galanthamine was used as reference AChE/BChE inhibitor. 
 
GC-MS analysis 
Mass spectra were obtained on a Varian Saturn 2200, a CP3800 GC coupled to an 
ion trap MS Saturn 2000 operating in EI mode, using a HP-5 MS column (30m x 0.25mm x 
0.25um, Agilent). The injector temperature was 280 ºC. The temperature program was as 
follows: 100-180 °C at 15 °C min-1, 1 min hold at 180 °C, 180-300 °C at 5 °C min-1, and 5 
min hold at 300 °C. The flow rate of carrier gas (Helium) was 0.8 ml min-1 and a split ratio 
of 1:20 was followed.  Data obtained were analyzed using AMDIS 2.64 software (NIST). 
The alkaloids were identified by comparing their GC-MS spectra with the information of 
the database of Amaryllidaceae alkaloids from the library developed by Dr. Bastida´s 
research group. The proportion of each individual component in the alkaloid fractions 
analyzed by GC-MS is expressed as a percentage of the total alkaloids in the fraction (TIC-
total ion current) (Table 1).  
Quantum calculations  
Quantum calculations were carried out using Gaussian 09 package.[49] Calculations 
were performed with full geometry optimization including in all cases the effect of the 
solvent (water as polar solvent) through the smd model,[50] B3LYP[51] and M06-2X[52] DFT 
functionals and 6-311+G (d,p) as basis set.[53, 54] We checked that the conformations 
obtained were minima by running frequency calculations. No imaginary vibrational 
frequencies were found. All energy values include zero-point correction. 
Molecular docking studies 
The complexes between ligands and receptors employed were obtained by 
molecular docking. The AChE from Torpedo Californica crystal structure (PDB: 1W6R) 
[41]   and human BChE crystal  (PDB: 1P0I)[55] were used to extract the geometries of the 
receptors, removing the ligand and water molecules.  
The protonation states of residues in the protein were assigned with H++ server.[56, 
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employing MarvinSketch v17.15.0 software package, assuming a pH of 7.4 as physiological 
value. [58] 
The program Autodock 4.2.6 was used for the docking simulations, employed 
Gasteiger charges for the protein and ligands.[59] The search space was defined using 
AutoGrid around the entire catalytic cavity with a size of 78 × 90 × 90 points for TcAChE 
and  68 x 68 x 60 for hBChE and a grid spacing of 0.375 Å. The search was made with 
genetic algorithm with the maximum number of energy evaluations was set to 5 x 106 and 
the maximum number of generations to 5 x 104 on a single population of 200 individuals. 
For each compound, the geometries generated and clustered with a RMSD threshold value 
of 2.0 Å. 
For each complex, a refinement of the binding energy was performed with Amber 
16.[60] The construction of the ligand units to be used was achieved with the antechamber 
module, using GAFF force field and AM1-BCC fitted charges. Input files for the 
simulations were built with the xleap package included in ambertools. For the refinement, 
two minimizations, of 5000 steps of the complexes were performed employing Sander 
software. The first one keeping the protein heavy atoms retrained at their initial positions 
and the second one with the whole system free. After the minimization steps, the binding 
free energies were calculated with molecular mechanics-Generalized Born surface area 
(MM-GBSA) approximations, using MMPBSA.py.[61, 62] The visualization of the docking 
result was performed with and Vmd v1.9 [63] and Maestro.[64] 
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